Euronav NV (NYSE:CMBT – Get Free Report) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 230,300 shares, an increase of 8.5% from the August 31st total of 212,200 shares. Currently, 1.5% of the company’s shares are short sold. Based on an average daily trading volume, of 159,400 shares, the days-to-cover ratio is currently 1.4 days.
Euronav Price Performance
Euronav stock traded up $0.20 during mid-day trading on Tuesday, reaching $16.82. 138,176 shares of the company traded hands, compared to its average volume of 674,189. Euronav has a 52-week low of $14.10 and a 52-week high of $21.26. The stock has a market capitalization of $3.39 billion, a price-to-earnings ratio of 7.45 and a beta of -0.08. The company has a debt-to-equity ratio of 1.54, a current ratio of 1.37 and a quick ratio of 1.32. The stock’s 50 day moving average price is $16.40.
Euronav (NYSE:CMBT – Get Free Report) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.24 by $0.22. The company had revenue of $233.66 million for the quarter. Euronav had a net margin of 112.38% and a return on equity of 22.35%. On average, sell-side analysts anticipate that Euronav will post 1.46 EPS for the current year.
Euronav Announces Dividend
About Euronav
Euronav NV, together with its subsidiaries, engages in the transportation and storage of crude oil worldwide. The company offers floating, storage, and offloading (FSO) services. It also owns and operates a fleet of vessels. The company was incorporated in 2003 and is headquartered in Antwerp, Belgium.
Recommended Stories
- Five stocks we like better than Euronav
- 5 discounted opportunities for dividend growth investors
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Investing in Commodities: What Are They? How to Invest in Them
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Stock Market Upgrades: What Are They?
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Euronav Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Euronav and related companies with MarketBeat.com's FREE daily email newsletter.